BioSpace News Archive

Business

Glenmark Pharmaceuticals and Harbour BioMed Sign Agreement for Greater China to Develop GBR 1302, a First-in-Class Bispecific Antibody for Treatment of HER2-Positive Cancers

Exclusive license agreement potentially worth more than $120 million in addition to royalties

August 6, 2018
·
4 min read
Biotech Bay

Protagonist Therapeutics Secures $22 Million Equity Financing

The transaction is expected to close on Aug. 8, 2018.

August 6, 2018
·
3 min read
Drug Development

Final Results from the Protagonist PROPEL Study Support Further Clinical Development of PTG-100 for the Treatment of Ulcerative Colitis

Independent blinded re-read of endoscopies provides signal of clinical efficacy and identifies human error in initial reads provided by contract research organization

August 6, 2018
·
8 min read
Business

Casma Therapeutics Expands Executive Team with Appointment of Two Senior Vice Presidents

Jeffrey Saunders, Ph.D., Casma’s new senior vice president of drug discovery, and Daniel Ory, M.D., as senior vice president of translational medicine.

August 6, 2018
·
3 min read
Business

Alzheon Appoints Former IVAX President, Neil Flanzraich, JD, as Vice Chairman of Board of Directors

Mr. Flanzraich was an early investor in Alzheon and served in the role of Chief Business Officer of Alzheon as a consultant to the company from February to May 2018.

August 6, 2018
·
4 min read
Business

Mallinckrodt Forms Collaborative Research Partnership with Washington University in St. Louis

Mallinckrodt to fund up to $10 million in collaborative research programs over five years to focus on rare diseases

August 6, 2018
·
4 min read
Business

OncoSec Enters Research Collaboration Agreement with UCLA and Roger S. Lo, M.D., Ph.D.

Dr. Lo is a preeminent physician-scientist widely recognized for his work in understanding treatment-resistant melanoma

August 6, 2018
·
3 min read
Drug Development

Eiger BioPharmaceuticals Announces First Patient Enrolled in Phase 2 LIFT Study of Pegylated Interferon Lambda in Combination with Ritonavir-Boosted Lonafarnib at National Institutes of Health

Eiger BioPharmaceuticals, Inc. announced first patient enrolled in the Phase 2 LIFT Study conducted within the National Institutes of Health (NIH) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

August 6, 2018
·
7 min read
Drug Development

Harpoon Therapeutics Treats First Patient with HPN424 in Phase 1 Clinical Trial of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients

Harpoon Therapeutics, today that the first patient has been treated with HPN424 in a Phase 1 clinical study of metastatic castration-resistant prostate cancer patients.

August 6, 2018
·
4 min read
Genetown

Simoa Technology Unlocks Insights from Previously Obscure Biomarker

Neurofilament light chain (NfL) proves to be a transformative biomarker for understanding wide range of neurological conditions and advancing clinical trials

August 6, 2018
·
5 min read